| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2020 , Vol 58 , Num 1
Obturator Neuropathy Combined with Guillain-Barre Syndrome
1 Istanbul Medipol University, School of Pharmacy, Department of Pharmacology, Istanbul, Turkey2 Istanbul Medipol University, School of Pharmacy, Department of Clinical Pharmacy, Istanbul, Turkey
3 Istanbul Medipol University, School of Pharmacy, Department of Biochemistry, Istanbul, Turkey
DOI : 10.23893/1307-2080.APS.05802 Viewed : 15690 - Downloaded : 3932 Keywords :